Yahoo
Canadian Sec - Free Realtime Quote CAD

Doseology Sciences Inc. (MOOD.CN)

0.0850 0.0000 (0.00%)
As of October 29 at 10:23:56 AM EDT. Market Open.
Chart Range Bar
Loading chart for MOOD.CN
  • Previous Close 0.0850
  • Open 0.0000
  • Bid 0.0200 x --
  • Ask --
  • Day's Range 0.0850 - 0.0850
  • 52 Week Range 0.0800 - 1.0000
  • Volume 0
  • Avg. Volume 2,311
  • Market Cap (intraday) 687,385
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1400
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors. The company was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc. in January 2020. Doseology Sciences Inc. was incorporated in 2019 and is based in Kelowna, Canada.

doseology.com

--

Full Time Employees

--

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

MOOD.CN
83.65%
S&P/TSX Composite index (^GSPTSE)
12.82%

1-Year Return

MOOD.CN
66.67%
S&P/TSX Composite index (^GSPTSE)
18.81%

3-Year Return

MOOD.CN
75.71%
S&P/TSX Composite index (^GSPTSE)
83.19%

5-Year Return

MOOD.CN
96.60%
S&P/TSX Composite index (^GSPTSE)
69.83%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    -0.1400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: